print small large

This application is a service of the Singapore Government.

Health Sciences Authority

Industry Communications on Therapeutic Product Regulations

22 June 2018: New self-guided algorithm and revised MIV enquiry form

Click here for details

1 April 2018: Update of Guidance on Therapeutic Product Registration (Apr 2018)

Click here for details

13 Nov 2017: New initiatives for Registration of Therapeutic Products

Click here for details

6 March 2017: Update on pilot project for MIV-1 verification

Click here for details

29 Dec 2016: Clarification on Retention of Therapeutic Product Registration and Update to Guidance on Therapeutic Product Registration

Click here for details

31 Oct 2016: Update on implementation of Health products: Revision of Guidance on Therapeutic Product Registration (1 Nov 16)

Click here for details

26 Sep 2016: Removal of Requirement of Submission of the Singapore Quality Overall Summary (SQOS)

The Singapore Quality Overall Summary (SQOS) was introduced in 2007 to provide information specific to product registration in Singapore. Over the years, the Therapeutic Products Branch (TPB) has received industry feedback that the SQOS is cumbersome to complete. Additionally, the information required by the SQOS may not be readily available, thereby delaying application submission.

In response to feedback received, several rounds of discussions and consultations were held before the decision was made to remove the requirement of submission of the SQOS. Information related to the product to be registered in Singapore will be obtained via the screening checklist in future. The current documentation submission requirements, including the ICH CTD / ASEAN CTD Quality Overall Summary will remain.

The removal of the SQOS will be effective from 1 November 2016.


1 Aug 2016: Industry feedback on Revised Guidance on Therapeutic Product Registration

Click here for details

20 June 2016: Pilot project on MIV-1 Verificiation Route

Click here for details

27 July 2015: National Consultation on the Proposed ASEAN Sectoral Mutual Recognition Agreement (NRA) on Bioequivalence (BE) Report

Click here for details.

13 April 2015: Update on ASEAN Mutual Recognition Arrangement (MRA) on GMP Inspection and GMP Conformity Assessment

Related documents:


9 Feb 2015: Streamlining of MIV-1 screening processes

Related documents:


1 Oct 2014: Update on HPRG's initiatives - Pilot Project on Screening Turnaround Time and MIV Updates

Related documents:

Update (20 Oct 14): 

Due to a delay in the enhancement of PRISM system for these changes, we wish to update you that the implementation date for the pilot project on screening TAT for MIV-1 applications, as well as the other initiatives pertaining to MIV applications stated in the email notification below (1 Oct 14), will be delayed from 01 November 2014 to 02 December 2014

March 2014:

Announcement – Update on Guidance on Medicinal Product Registration in Singapore

Related documents:

8 Jan 2014:

Updates for Guidance on Medicinal Product Registrationin Singapore

Revised MIV-1/MIV-2 checklists (effective 1 April 2014)

27 Sept 2013:

Industry Consultation on Drug Product Stability Data Requirements and ASEAN Variation Guideline Implementation (closing date 18 October 2013)

The consultation period for this paper is closed.

25 June 2013:

Industry Consultation on Site Specific DP Stability Requirement

The consultation period for this paper is closed.

March 2012:

Announcement - Revision to Guidance on Medicinal Product Registration in Singapore